1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Coloplast AS

Kristian Villumsen

Holtedam 1 3, Humlebaek 3050
Phone: 4549111111


Coloplast expands its Luja portfolio with next generation catheter for women
May 14, 2024 07:30am

The female intermittent catheter enables complete bladder emptying in one free flow1, aiming to reduce the risk of urinary tract infections2. Following the successful launch of Luja with Micro-hole Zone Technology, a next generation intermittent catheter for men, Coloplast is now launching Luja for women. “So far, we have received great feedback on Luja for men in our product evaluations. Jetzt den vollständigen Artikel lesen

Coloplast A/S (CLPBF) Q2 2023/2024 Earnings Call Transcript
May 10, 2024 18:38pm

No summary available.

Source:Seeking Alpha
Coloplast A/S 2024 Q2 - Results - Earnings Call Presentation
May 10, 2024 15:55pm

No summary available.

Source:Seeking Alpha
CLPBY Stock Earnings: Coloplast Reported Results for Q2 2024
May 07, 2024 17:54pm

Coloplast (OTCMKTS: CLPBY ) just reported results for the second quarter of 2024. Coloplast reported earnings per share of 8 cents. The company reported revenue of $959.13 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future” The post CLPBY Stock Earnings: Coloplast Reported Results for Q2 2024 appeared first on InvestorPlace .

Coloplast strengthens ostomy care portfolio with three significant product launches
May 07, 2024 05:04am

The company has received reimbursement approval in the UK for Heylo™, the world’s first digital leakage notification system, and expands its SenSura® Mio ostomy range with two new products.